ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2011

Nov 8, 2011

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2011-10-26

Reporting Person: GIVEN BRUCE D (Chief Operating Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option dated 10/26/2011	$0.52	2021-10-26	Common Stock (300000)		Direct
Stock Option dated 09/28/2009	$0.62	2019-09-28	Common Stock (10000)		Direct

Footnotes

F1: Vests 1/8 on six month cliff and balance equally over 42 months.

F2: Vests 1/8 on six month cliff and balance equally over 42 months.